Publications by authors named "Fukiko Mitsui"

Claim this Profile
M
Modifying Effect of Chronic Atrophic Gastritis on Radiation Risk for Noncardia Gastric Cancer According to Histological Type.
Keiko Ueda, Waka Ohishi, Harry Cullings, Saeko Fujiwara, Gen Suzuki, Fukiko Mitsui

Radiat Res· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing triple therapy and IFN/RBV-free regimens for hepatitis C virus infection.
Kazuaki Chayama, Fukiko Mitsui, C Nelson Hayes

Expert Rev Gastroenterol Hepatol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A first case of hepatic angiosarcoma treated with recombinant interleukin-2.
Fukiko Mitsui, Hiroshi Aikata, Yoshimasa Hashimoto, Yuko Nagaoki, Yuki Kimura

Hiroshima J Med Sci· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.
Hiromi Abe, Michio Imamura, Nobuhiko Hiraga, Masataka Tsuge, Fukiko Mitsui

J Hepatol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of hepatitis B virus infection on the interferon response in immunodeficient human hepatocyte chimeric mice.
Masataka Tsuge, Shoichi Takahashi, Nobuhiko Hiraga, Yoshifumi Fujimoto, Yizhou Zhang, Fukiko Mitsui

J Infect Dis· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapy.
Hiromi Abe, C Nelson Hayes, Hidenori Ochi, Toshiro Maekawa, Masataka Tsuge, Fukiko Mitsui

J Hepatol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of response to peginterferon-alfa-2b plus ribavirin therapy in Japanese patients infected with hepatitis C virus genotype 1b.
Yoshimasa Hashimoto, Hidenori Ochi, Hiromi Abe, Yasufumi Hayashida, Masataka Tsuge, Fukiko Mitsui

J Med Virol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elimination of hepatitis C virus by short term NS3-4A and NS5B inhibitor combination therapy in human hepatocyte chimeric mice.
Eiji Ohara, Nobuhiko Hiraga, Michio Imamura, Eiji Iwao, Naohiro Kamiya, Fukiko Mitsui

J Hepatol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amino acid substitutions in core and NS5A regions of the HCV genome can predict virological decrease with pegylated interferon plus ribavirin therapy.
Shosuke Kitamura, Masataka Tsuge, Tsuyoshi Hatakeyama, Hiromi Abe, Michio Imamura, Fukiko Mitsui

Antivir Ther· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive value of the IL28B polymorphism on the effect of interferon therapy in chronic hepatitis C patients with genotypes 2a and 2b.
Tomokazu Kawaoka, C Nelson Hayes, Waka Ohishi, Hidenori Ochi, Toshiro Maekawa, Fukiko Mitsui

J Hepatol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolongation of interferon therapy for recurrent hepatitis C after living donor liver transplantation: analysis of predictive factors of sustained virological response, including amino acid sequence of the core and NS5A regions of hepatitis C virus.
Tomokazu Kawaoka, Nobuhiko Hiraga, Shoichi Takahashi, Shintaro Takaki, Fukiko Mitsui

Scand J Gastroenterol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Common variation of IL28 affects gamma-GTP levels and inflammation of the liver in chronically infected hepatitis C virus patients.
Hiromi Abe, Hidenori Ochi, Toshiro Maekawa, C Nelson Hayes, Masataka Tsuge, Fukiko Mitsui

J Hepatol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Importance of serum concentration of adefovir for Lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B.
Fukiko Mitsui, Masataka Tsuge, Takashi Kimura, Shosuke Kitamura, Hiromi Abe

Antimicrob Agents Chemother· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HBx protein is indispensable for development of viraemia in human hepatocyte chimeric mice.
Masataka Tsuge, Nobuhiko Hiraga, Rie Akiyama, Sachi Tanaka, Miyuki Matsushita, Fukiko Mitsui

J Gen Virol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
G to A hypermutation of TT virus.
Masataka Tsuge, Chiemi Noguchi, Rie Akiyama, Miyuki Matsushita, Kana Kunihiro, Fukiko Mitsui

Virus Res· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of structural variations of APOBEC3A and APOBEC3B genes in chronic hepatitis B virus infection.
Hiromi Abe, Hidenori Ochi, Toshiro Maekawa, Tsuyoshi Hatakeyama, Masataka Tsuge, Fukiko Mitsui

Hepatol Res· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absence of viral interference and different susceptibility to interferon between hepatitis B virus and hepatitis C virus in human hepatocyte chimeric mice.
Nobuhiko Hiraga, Michio Imamura, Tsuyoshi Hatakeyama, Shosuke Kitamura, Fukiko Mitsui

J Hepatol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The first Japanese case of COACH syndrome.
Fukiko Mitsui, Hiroshi Aikata, Takahiro Azakami, Yoshio Katamura, Takashi Kimura

Hepatol Res· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis